Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis

NCT01177228 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Vedolizumab
DRUG: Placebo

Sponsor

Millennium Pharmaceuticals, Inc.